Experimental treatment for COPD in development
Researchers at the Johns Hopkins Bloomberg School of Public Health have discovered a way to stimulate lung's immune defenses against infection, holding promise for sufferers of chronic obstructive pulmonary disease (COPD).
Immune system's bare essentials used to speedily detect drug targets
Scientists can spend years trying to figure out where to aim a drug therapy. Hopkins researchers offer a new method for identifying the best "route" a groundbreaking discovery that can expedite progress in research and diagnostic labs worldwide.
Biodegradable particles can bypass mucus, release drugs over time
Hopkins researchers have created biodegradable, nanosized particles that surpass mucus barriers to deliver sustained-release medications. Their discovery has the potential to affect treatments from head to toe.